iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction
- Status
- UNKNOWN
- Phase
- PHASE1
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NADIM II: Neo-Adjuvant Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention
- Status
- COMPLETED
- Phase
- PHASE1